Other ANGLE Investments
Novocellus
Novocellus has developed a patent protected system, EmbryoSure, for selecting embryos likely to lead to a successful pregnancy...
read more
Geomerics
Geomerics has successfully developed and launched its 'Enlighten' product, dramatically improving the lighting of computer games...
read more
NeuroTargets
NeuroTargets focuses on the co-development of novel therapeutic products with innovative mechanisms of action related to nerve injury...
read more
Share Price
58.75p
Chg: +5.25p
Chg: (9.81%)
23 May 2013
ANGLE is quoted
on AIM (AGL)